Differential blockade of central effects of angiotensin II by AT2-receptor antagonists.
R E Widdop, S M Gardiner, P A Kemp, T Bennett
文献索引:Am. J. Physiol. 265 , H226, (1993)
全文:HTML全文
摘要
In conscious, chronically instrumented, male Long-Evans rats, we showed previously that central administration (intracerebroventricular) of the AT1-receptor antagonist EXP-3174 (1 microgram) caused a rapid-onset marked, but transient, blockade of the regional hemodynamic responses to intracerebroventricular angiotensin II (ANG II). In contrast, the AT2-receptor antagonist PD-123319 (80 micrograms) caused a slow-onset, but marked and persistent, antagonism of the effects of intracerebroventricular ANG II. In the present study we attempted to mimic the actions of PD-123319 by giving a supramaximal dose of EXP-3174 (10 micrograms), and we also assessed the effects of PD-123177 (80 micrograms), an AT2-receptor antagonist that differs from PD-123319 only by a dimethyl group. The higher dose of EXP-3174 did not exert prolonged antagonistic effects against responses to intracerebroventricular ANG II, and PD-123177 was without inhibitory effects in this model. The results indicate important functional differences between putative AT2-receptor antagonists, when assessed in vivo, that are not apparent from binding studies.
相关化合物
相关文献:
2008-06-01
[Placenta 29(6) , 503-9, (2008)]
1992-04-01
[Mol. Pharmacol. 41 , 809-815, (1992)]
1994-06-01
[J. Neurochem. 62 , 2106-2115, (1994)]
2010-04-01
[Am. J. Physiol. Regul. Integr. Comp. Physiol. 298 , F847-F856, (2010)]